ClinicalTrials.gg
Status unknownNCT03406728Updated Jan 23, 2018

Virtual Reality Can be Used to Improve Balance Reducing Dynamic Falls in Those With Parkinson's Disease

An interventional study of PDSAFEX and CONTROL in Parkinson Disease, sponsored by Sun Life Financial Movement Disorders Research and Rehabilitation Centre. Status unknown at 1 site in Canada. Open to participants aged 55 Years to 90 Years. Per ClinicalTrials.gov, last updated 2018-01-23.

Sponsored by Sun Life Financial Movement Disorders Research and Rehabilitation Centre · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
55 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 10 studies in Parkinson Disease by Sun Life Financial Movement Disorders Research and Rehabilitation Centre — none open to participants now, none under way, none of them phase 3. Parkinson Disease · Sun Life Financial Movement Disorders Research and Rehabilitation Centre.

Planned enrollment
8th of 10
36 · median 57
Started
2018
with 2 others
No phase
10 of 10
none open now
Registered
7th of 10
by date

Among the 10 studies in Parkinson Disease by Sun Life Financial Movement Disorders Research and Rehabilitation Centre, this one is the 8th largest by planned enrollment, is one of 3 that started in 2018, is one of 10 with no phase, and was the 7th registered.

Parkinson Disease

4,573 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

None of the 10 studies in Parkinson Disease by Sun Life Financial Movement Disorders Research and Rehabilitation Centre is open now.

Where they have run

Who these studies take

Of the 748 Parkinson Disease studies recruiting now, 311 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 63 take children under 18; 189 take healthy volunteers.

This study: 55 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 10 studies in Parkinson Disease by Sun Life Financial Movement Disorders Research and Rehabilitation Centre as a file.
02

Study summary

This study aims to explore the use of full immersion virtual reality technology on improving balance in those with Parkinson's Disease. Patients will be immersed in a virtual environment and be tasked with completed games and activities, which mirror activities of daily living. It is hypothesized that this immersion in the virtual reality environment will improve their sensory pathways which are used to improve balance, decreasing falls.

Read the detailed description

I will utilize a randomized independent measures single blind study. Meaning participants will be randomly assigned to three different groups. The randomization process will be completed by the primary investigator, using a computer randomization software. Essentially, participants will all be given numbers which will be entered into the software, which then randomly assigns them to one of the three groups. The groups are: the virtual reality intervention group, the PDSAFEX group and the control group. Dr. Almeida, the tester of UPDRS scores, will be unaware of which groups each participant is in - only I will be aware. I aim to recruit about thirty-six individuals (12 per group). The study will last twelve weeks. It will include: pre-testing and post-testing with a one month follow up. However, due to time constrains the post testing may be completed after 8 weeks so I can begin to analyze data and have a write up for my classmates and professors. There will still be the scheduled post testing and follow up after the fact at the specified original times (12 weeks and 1 month follow up). Participants will come into the MDRC three times per week. Depending on their group they will complete the PDSAFEX training or VR training intervention. PDSAFEX is a scripted intervention run by trained volunteers, it progresses in difficulty week by week. The VR technology group will complete a protocol that is associated with the software system of the device. They will be asked to complete exercises and/games aimed specifically at improving balance. For example, a game where they must dodge incoming objects while maintain good balance. Virtual reality, is also able to be increased in difficulty through changing the environment and/or stimuli characteristics/speed.

The virtual reality group will be exposed to the virtual reality simulation software for about 1 hour and 15 minutes including set up. They will complete a set of activities, games and exercises that are centered around improving balance. The activities and games are included in the software. The environment and difficulty of the protocol can be altered to make it more/less difficult depending on the participant's ability and/progression throughout the study.

The PDSAFEX intervention was created to improve an individual's sensory integration with a focus on improving balance. It consists of a 12-week protocol administered by trained volunteers. Each session lasts about 1 hour. Each week of the PDSAFEX protocol increases in either difficulty/volume to allow consistent improvements. Furthermore, some of the conditions/exercises are attempted under dim lights or with eyes closed to further stress the focus on limiting visual domains. Focusing on proprioception.

The control group will come in to the MDRC facility, to complete testing (pre, post and follow up). The participants in this group will be asked to continue their lifestyles without any drastic changes for the duration of the study.

03

Conditions studied

  • Parkinson Disease

Browse trials for

Keywords

  • Parkinson's Disease
  • Virtual Reality
  • Training
  • Balance
  • Falls
  • PDSAFEX
04

Who can participate

Ages eligible
55 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Confirmed with diagnosis with Parkinson's Disease by a registered movement disorders specialist
  • Either gender
  • Currently taking dopaminergic medication
  • Able to walk 15m, unassisted
  • Able to stand for 2 minutes unassisted
  • Able to understand English Instructions
  • Normal or corrected visions

Exclusion criteria

Exclusion Criteria:

  • Any other neurological disorder
  • MoCa Score less than 18
  • Commonly experiences vertigo, dizziness or motion sickness
  • Seizures or dizziness due to light
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Active comparator
    PDSAFEX GROUP

    Parkinson's Disease Sensory Attention Focused Exercise (PDSAFEX) is an exercise intervention developed in light of research which focuses on utilizing sensory integration and proprioception to improve balance. This intervention will be administered to one group of my participants. The protocol will be followed and led by trained volunteers.

    Other: PDSAFEX

  • Active comparator
    CONTROL GROUP

    The control group in this study will be asked to maintain their daily lifestyle as closely as possible for the 12-week duration of the study.

    Other: CONTROL

  • Experimental
    VIRTUAL REALITY GROUP

    Virtual reality intervention will be assigned to this group. They will complete activities aimed at improving their dynamic balance. These activities are specifically developed based on previous literature and geared towards mirroring day to day activities/scenarios that individuals with PD may come into contact with.

    Device: VIRTUAL REALITY

Interventions

  • OtherPDSAFEX

    PDSAFEX is a week by week, progressive, exercise protocol that is followed. It lasts 12 weeks.

  • OtherCONTROL

    Participants will be asked to maintain their day to day life as consistently as possible for the 12 week duration of the study.

  • DeviceVIRTUAL REALITY

    WorldViz Oculus Rift Move package (headset and software).

06

What researchers measure

Primary outcomes

  1. Change in Unified Parkinson's Disease Rating Scale (UPDRS)

    Assesses the burden and extent of Parkinson's Disease over the course of the disease.

    Time frame: Pre test (a week prior), post test after 8 weeks and follow up with a washout period one month after completion of study.

  2. Change in Sensory Organization Tests (SOT- 6)

    The sensory organization test is a set of six tests which measures an individuals balance under six different conditions. More specifically, it assess quantitative data about visual, proprioceptive and vestibular cues in order to maintain postural stability in stanceIt is completed using the Biodex machine.

    Time frame: Pre test (a week prior), post test after 8 weeks and follow up with a washout period one month after completion of study.

  3. Change in the number of Falls utilizing a Fall Calendar

    Subjective response that identifies the number of falls an individual participant has experienced. Participants will be supplied with a falls calendar which they will fill out and bring back in to the primary researcher.

    Time frame: The calendar will be completed daily but the results handed in at the end of each month for the duration of the study. The study will last three months, as such there should be three completed calendars.

Secondary outcomes

  1. Change in Timed up and Go (TUG)

    The timed up and go test is an objective measure of balance, walking ability and fall risk in older adults.

    Time frame: Pre test (a week prior), post test after 8 weeks and follow up with a washout period one month after completion of study.

  2. Change in Activities Specific Balance Confidence scale (ABC scale)

    A subjective measure of confidence in completing certain activities of daily living or ambulatory actions without falling or experiencing unsteadiness.

    Time frame: Pre test (a week prior), post test after 8 weeks and follow up with a washout period one month after completion of study.

  3. Change in Gait Analysis

    Measurement of an individuals step length, stride length, step variability and center of pressure. The results are all computed through the software; it provides you with all of the results after each trial of the test.

    Time frame: Pre test (a week prior), post test after 8 weeks and follow up with a washout period one month after completion of study.

  4. Change in Falls Efficacy Scale (FES)

    Assesses the perception of balance, stability and the fear of falling during activities of daily living.

    Time frame: Pre test (a week prior), post test after 8 weeks and follow up with a washout period one month after completion of study.

  5. Change in Parkinson's Disease Questionnaire (PDQ-39)

    A self report questionnaire which assesses an individual's Parkinson's specific health quality over quality over the last month, their experience and difficulties in completing activities in the eight quality of life dimensions and the impact of Parkinson's on specific areas of wellbeing and functioning.

    Time frame: Pre test (a week prior), post test after 8 weeks and follow up with a washout period one month after completion of study.

07

Study locations

1 site
  • Sun Life Financial Movement Disorders Research and Rehabilitation Centre
    Waterloo, Ontario N2L 3C5, Canada
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2018; primary completion for Apr 2018, 3 months later.

Of 1,291 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 3 months is below that.

Counting every sponsor, half of 1,367 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 8, 2018
First posted
Jan 23, 2018
StartEst.
Jan 21, 2018
Primary completionEst.
Apr 30, 2018
CompletionEst.
May 30, 2018
Last update
Jan 23, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03406728
Lead sponsor
Sun Life Financial Movement Disorders Research and Rehabilitation Centre
Responsible party
Sponsor
First posted
Jan 23, 2018
Start date
Jan 21, 2018 (estimated)
Primary completion
Apr 30, 2018 (estimated)
Completion
May 30, 2018 (estimated)
Last update
Jan 23, 2018

Study contacts

Luke A. Simpson
Contact
simp0290@mylaurier.ca
2892219050
Quincy J Almeida, PhD
study director · SunLife Movement Disorders Research and Rehabilitation Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion